These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2183224)

  • 41. Ets1 was significantly activated by ERK1/2 in mutant K-ras stably transfected human adrenocortical cells.
    Chen YF; Shin SJ; Lin SR
    DNA Cell Biol; 2005 Feb; 24(2):126-32. PubMed ID: 15699632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS.
    Yang MH; Laurent G; Bause AS; Spang R; German N; Haigis MC; Haigis KM
    Mol Cancer Res; 2013 Sep; 11(9):1072-7. PubMed ID: 23723075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lovastatin induces apoptosis in malignant mesothelioma cells.
    Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Posttranslational modification of proteins by isoprenoids in mammalian cells.
    Maltese WA
    FASEB J; 1990 Dec; 4(15):3319-28. PubMed ID: 2123808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
    Keller RK; Zhao Z; Chambers C; Ness GC
    Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of cellular p21ras by myristoylation.
    Buss JE; Solski PA; Schaeffer JP; MacDonald MJ; Der CJ
    Biochem Soc Trans; 1989 Oct; 17(5):867-9. PubMed ID: 2695362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts.
    Vogt A; Qian Y; McGuire TF; Hamilton AD; Sebti SM
    Oncogene; 1996 Nov; 13(9):1991-9. PubMed ID: 8934546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solution- and solid-phase synthesis of the polybasic lipid-modified C termini of Rho A and K-Ras 4B.
    Ludolph B; Eisele F; Waldmann H
    Chembiochem; 2002 Sep; 3(9):901-4. PubMed ID: 12210992
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isoprenoid metabolism is required for stimulation of the respiratory burst oxidase of HL-60 cells.
    Bokoch GM; Prossnitz V
    J Clin Invest; 1992 Feb; 89(2):402-8. PubMed ID: 1310693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition.
    García-Román N; Alvarez AM; Toro MJ; Montes A; Lorenzo MJ
    Mol Cell Neurosci; 2001 Feb; 17(2):329-41. PubMed ID: 11178870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A human Ki-ras oncogene encodes two transforming p21 proteins.
    McCoy MS; Weinberg RA
    Mol Cell Biol; 1986 Apr; 6(4):1326-8. PubMed ID: 3537700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proto-oncogenic H-Ras, K-Ras, and N-Ras are involved in muscle differentiation via phosphatidylinositol 3-kinase.
    Lee J; Choi KJ; Lim MJ; Hong F; Choi TG; Tak E; Lee S; Kim YJ; Chang SG; Cho JM; Ha J; Kim SS
    Cell Res; 2010 Aug; 20(8):919-34. PubMed ID: 20603646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Ras-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445.
    Tikoo A; Cutler H; Lo SH; Chen LB; Maruta H
    Cancer J Sci Am; 1999; 5(5):293-300. PubMed ID: 10526670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in females.
    Calvert RJ; Tepper S; Diwan BA; Anderson LM; Kritchevsky D
    Biochem Pharmacol; 2003 Aug; 66(3):393-403. PubMed ID: 12907238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell cycle-specific effects of lovastatin.
    Jakóbisiak M; Bruno S; Skierski JS; Darzynkiewicz Z
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3628-32. PubMed ID: 1673788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation.
    Miller AC; Kariko K; Myers CE; Clark EP; Samid D
    Int J Cancer; 1993 Jan; 53(2):302-7. PubMed ID: 8425769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Palmitoylation of oncogenic NRAS is essential for leukemogenesis.
    Cuiffo B; Ren R
    Blood; 2010 Apr; 115(17):3598-605. PubMed ID: 20200357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.